I just gave this lecture at the 2019 Interventional Orthopedics Foundation Annual Meeting. At the Dallas PRP and Stem Cell Institute we only use your own bone marrow as the source for stem cell procedures. Anything out of a bottle is either not legal or a scam so avoid those providers at all costs.
My primary interests are sports medicine orthopedics, orthobiologics, and shoulder and knee surgery. Here are some ways to find more content on these topics!
Here is another example of how we analyze and document every single PRP injection in the office so that we can develop dosing criteria for specific orthopedic applications. Two weeks ago this young baseball athlete had a BMC (bone marrow derived stem cell) injection for a partial ulnar collateral ligament tear.
My recent Regenerative Medicine podcast with Dr. Andrew Dold is now available! Dr. Dold is an orthopedic surgeon who has a sports medicine podcast just started on iTunes and Soundcloud. The first episode was with well known sports medicine orthopedic surgeon, Dr. Jim Andrews. In this episode 2 Dr. Dold and I talk about the growing use of orthobiologics in sports medicine to help patients recover from injuries with or without surgery. Have a listen! We are always trying to improve upon surgical and nonsurgical outcomes by augmenting our own native healing processes with orthobiologics.
One of our best options to fight the opioid epidemic (in orthopedics) is with orthobiologics. At the Dallas PRP and Stem Cell Institute we use platelet rich plasma and bone marrow derived stem cells for patients with chronic, painful orthopedic conditions like osteoarthritis.
On October 15, 2018 Gina Kolata of the NY Times published an article detailed Harvard University’s retraction of dozens of articles by cardiologist Dr. Piero Anversara. Dr. Anversa has published about 31 studies detailing how mesenchymal stem cells from bone marrow could be injected to regenerative cardiac (heart) muscle tissue. If true, the scientific find would have been revolutionary as a potential new treatment for patients who suffer heart attacks or other cardiac diseases.
30 second example of an obstructive meniscal tear that often continues to cause knee dysfunction despite nonsurgical treatment. The degenerative tears have been shown in multiple studies to get better most of the time without surgery, orthobiologics, or anything more than physical therapy. A meniscus tear diagnosis on a MRI reading is not a reason for any invasive procedure….rest, rehab….time…will allow most patients to return to their “baseline” knee function.
On September 28, 2018, the Liveyon company started a product recall of their umbilical cord blood products produced by Genetech in San Diego because of contamination with E. coli. There is no reason to use a riskier allograft orthobiologic when there are more studied, cheaper, safer alternatives that come from our own bodies!
Don’t get scammed by a clinic selling “umbilical cord blood as a living stem cell”. The clinic in question has been in Plano and Arlington Texas for a long time defrauding patients.
We had a good example yesterday of how important it is to quantify the orthobiologic and also how much variance there can be in the same patient on the same day. Our first draw resulted in 12.43X LP-PRP with a nice shift away from granulocytes(decreased). The patient decided they wanted to treat an additional region so we drew more blood. About a 30 minute time interval max. Exact same tech, same doc, same centrifuge, same hematology machine, etc…. and this time the PRP was 7.29X LP-PRP with a shift away from granulocytes again.
